Skip to main content
SpringerLink
Log in

CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

CD105 is an ancillary receptor of transforming growth factor beta (TGF-β), which has been suggested as a suitable biomarker for cancer-related angiogenesis and neovascularization (Nassiri et al. in Anticancer Res 31:2283–2290, 2011). However, the clinical significance of CD105 in WHO grade was rarely reported and the effects of CD105 signal transduction pathway on gliomas remain controversial and unclear. To get a convincing conclusion, performing a meta-analysis is essential. Relevant literature studies were included via careful evaluation, and standard mean difference (SMD) and hazard ratio (HR) with 95 % confidence intervals (95 % CIs) was calculated. We also made funnel plots to test the heterogeneity. In the present meta-analysis, a total of 11 eligible literatures involving 796 patients were incorporated. They were all conducted in China, revealing that CD105 overexpression in glioma tissues was strongly linked to high WHO grading (III+IV) (SMD −1.785, 95 % CI −2.133, −1.437; p = 0.000). No significant associations between CD105 and age (SMD −0.505, 95 % CI −1.054, 0.043; p = 0. 071), CD105 and gender (SMD 0.101, 95 % CI −0.103, 0.305; p = 0.333), and CD105 and tumor size (SMD −0.433, 95 % CI −1.326, 0.459; p = 0. 341) were detected. Besides, CD105 expression was closely associated with glioma patients’ 3-year overall survival (OS; n = 2; HR = 4.357, 95 % CI 1.412, 7.303; p = 0.004). On the basis of Begg’s and Egger’s test or funnel plot, no publication bias was detected. In a nutshell, this meta-analysis demonstrated that CD105 overexpression correlates to higher WHO grade and poor survival and could be indicated as a helpful prognostic and diagnostic marker, or a useful therapy target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Taal W, Bromberg JE, van den Bent MJ (2015) Chemotherapy in glioma. CNS Oncol 4:179–192

  2. Venneti S, Huse JT (2015) The evolving molecular genetics of low-grade glioma. Adv Anat Pathol 22:94–101

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Quackenbush EJ, Letarte M (1985) Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J Immunol 134:1276–1285

    CAS  PubMed  Google Scholar 

  4. Wong SH, Hamel L, Chevalier S, Philip A (2000) Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-beta signalling receptors. Eur J Biochem 267:5550–5560

    Article  CAS  PubMed  Google Scholar 

  5. Nassiri F, Cusimano MD, Scheithauer BW et al (2011) Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 31:2283–2290

    CAS  PubMed  Google Scholar 

  6. Wikstrom P, Lissbrant IF, Stattin P, Egevad L, Bergh A (2002) Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51:268–275

    Article  CAS  PubMed  Google Scholar 

  7. Martinez LM, Labovsky V, de Lujan CM et al (2015) CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients. PLoS One 10:e121421

    Google Scholar 

  8. Nair S, Nayak R, Bhat K, Kotrashetti VS, Babji D (2015) Immunohistochemical expression of CD105 and TGF-beta1 in oral squamous cell carcinoma and adjacent apparently normal oral mucosa and its correlation with clinicopathologic features. Appl Immunohistochem Mol Morphol 24:35–41

  9. Lytras D, Leontara V, Kefala M et al (2015) Microvessel landscape assessment in pancreatic ductal adenocarcinoma: unclear value of targeting endoglin (CD105) as prognostic factor of clinical outcome. Pancreas 44:87–92

    Article  PubMed  Google Scholar 

  10. Smith SJ, Tilly H, Ward JH et al (2012) CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma. Acta Neuropathol 124:99–110

    Article  PubMed  PubMed Central  Google Scholar 

  11. Clara CA, Marie SK, de Almeida JR et al (2014) Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1alpha in human glioblastoma. Neuropathology 34:343–352

    CAS  PubMed  Google Scholar 

  12. Wang YF, Wang DL, Shi GS, Huang H (2006) Expressions of hTERT, HIF-1alpha and CD105 in gliomas and their clinical significance. Zhonghua Bing Li Xue Za Zhi 35:681–682

    PubMed  Google Scholar 

  13. Steels E, Paesmans M, Berghmans T et al (2001) Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 18:705–719

    Article  CAS  PubMed  Google Scholar 

  14. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16

    Article  PubMed  PubMed Central  Google Scholar 

  15. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815–2834

    Article  CAS  PubMed  Google Scholar 

  16. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wang D, Mou ZY, Zhai JX, Zong HX, Zhao XD (2008) Application of Stata software to test heterogeneity in meta-analysis method. Zhonghua Liu Xing Bing Xue Za Zhi 29:726–729

    CAS  PubMed  Google Scholar 

  18. Dickersin K, Berlin JA (1992) Meta-analysis: state-of-the-science. Epidemiol Rev 14:154–176

    Article  CAS  PubMed  Google Scholar 

  19. Stuck AE, Rubenstein LZ, Wieland D (1998) Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 316(469):470–471

    Google Scholar 

  20. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676–680

    Article  CAS  PubMed  Google Scholar 

  21. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097

  22. Paschoal JP, Bernardo V, Canedo NH, Ribeiro OD, Caroli-Bottino A, Pannain VL (2014) Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression. BMC Cancer 14:72

    Article  PubMed  PubMed Central  Google Scholar 

  23. Hawinkels LJ, Kuiper P, Wiercinska E et al (2010) Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70:4141–4150

    Article  CAS  PubMed  Google Scholar 

  24. Castonguay R, Werner ED, Matthews RG et al (2011) Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J Biol Chem 286:30034–30046

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Tan GH, Tian L, Wei YQ et al (2004) Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities. Int J Cancer 112:701–706

    Article  CAS  PubMed  Google Scholar 

  26. Wood LM, Pan ZK, Guirnalda P, Tsai P, Seavey M, Paterson Y (2011) Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105. Cancer Immunol Immunother 60:931–942

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Paauwe M, Ten DP, Hawinkels LJ (2013) Endoglin for tumor imaging and targeted cancer therapy. Expert Opin Ther Targets 17:421–435

    Article  CAS  PubMed  Google Scholar 

  28. Liu Y, Tian H, Blobe GC, Theuer CP, Hurwitz HI, Nixon AB (2014) Effects of the combination of TRC105 and bevacizumab on endothelial cell biology. Invest New Drugs 32:851–859

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Rockwell S, Kimler BF, Moulder JE (2006) Publishing negative results: the problem of publication bias. Radiat Res 165:623–625

    Article  CAS  PubMed  Google Scholar 

  30. Popov S, Jury A, Laxton R et al (2013) IDH1-associated primary glioblastoma in young adults displays differential patterns of tumour and vascular morphology. PLoS One 8, e56328

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Chakhachiro ZI, Zuo Z, Aladily TN et al (2013) CD105 (endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemias. Am J Clin Pathol 140:370–378

    Article  CAS  PubMed  Google Scholar 

Download references

Funding statement

This study was supported by the Research Special Fund for Public Welfare Industry of Health (Project No. 201402008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Author notes

    Authors and Affiliations

    1. Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan Hutong of Dongcheng District, Beijing, 100730, China

      Xiangyi Kong, Yu Wang, Shuai Liu, Bing Xing, Yi Yang, Yongning Li, Zuyuan Ren, Changbao Su, Wenbin Ma & Renzhi Wang

    Authors
    1. Xiangyi Kong
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Yu Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Shuai Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Bing Xing
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Yi Yang
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Yongning Li
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Zuyuan Ren
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Changbao Su
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Wenbin Ma
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Renzhi Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Wenbin Ma or Renzhi Wang.

    Ethics declarations

    Conflict of interest

    The authors state that there are no conflicts of interest to disclose.

    Additional information

    Xiangyi Kong, Yu Wang and Shuai Liu contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Kong, X., Wang, Y., Liu, S. et al. CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas. Mol Neurobiol 53, 3503–3512 (2016). https://doi.org/10.1007/s12035-015-9677-1

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12035-015-9677-1

    Keywords

    Search

    Navigation